RAPT Therapeutics, Inc. — Director's Dealing 2021

Aug 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-08-20

Reporting Person: Robbins Wendye (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-20	Common Stock	P	100	$29.815	Acquired	7900	Direct
2021-08-20	Common Stock	P	500	$29.47	Acquired	8400	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1300	Indirect
Common Stock	305	Indirect